Učitavanje...
Correction: Tislelizumab in Chinese patients with advanced solid tumors: an open-label, non-comparative, phase 1/2 study
Spremljeno u:
| Izdano u: | J Immunother Cancer |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BMJ Publishing Group
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7371019/ https://ncbi.nlm.nih.gov/pubmed/32690666 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2019-000437corr1 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|